Date and Time December 3, 20242:00–4:00 p.m. ET OverviewAre you interested in learning about training opportunities available in the National Institute of Mental Health (NIMH) Intramural Research Program (IRP)? Join the Office of Fellowship Training for a virtual information session to learn about a variety of National Institutes of Health (NIH) training programs, exciting research being…
Summary: A scientific validation study conducted by SleepScore Labs found that Rebalance Health Systems lozenges significantly improve sleep. The study analyzed approximately 2,000 nights of sleep using SleepScore Max, a non-contact monitoring device, and showed that participants experienced faster sleep onset, fewer awakenings, less time awake during the night, and better sleep efficiency compared to…
Summary: Tonix Pharmaceuticals presented new data at the American College of Rheumatology’s 2024 meeting, demonstrating that its drug candidate TNX-102 SL significantly reduces pain and improves sleep quality in fibromyalgia patients. In the phase 3 RESILIENT study, the drug met its primary endpoint and showed improvements across all secondary endpoints, including sleep and fatigue. Tonix…
Summary: REMSleep Holdings has announced a delay in the market release of its Deltawave nasal pillows CPAP mask, now anticipated to launch in January 2025. The company attributes the delay to challenges with regulatory compliance and supply chain coordination, particularly for critical materials like medical-grade silicone. Despite setbacks, REMSleep notes it remains focused on ensuring…
Summary: NLS Pharmaceutics Ltd is investigating two novel dual orexin receptor agonists (DOXAs), AEX-41 and AEX-2, in a preclinical study to assess their potential for treating narcolepsy. The research, conducted at the Centre for Neuroscience Research of Lyon, focuses on promoting wakefulness, enhancing sleep quality, and reducing cataplexy in an orexin knockout mouse model. By…
Summary: A 2024 survey by the American Academy of Sleep Medicine (AASM) shows that 51% of Americans have never discussed their sleep concerns with a healthcare provider, despite over half believing they don’t get enough sleep. The AASM highlights that these conversations can help diagnose sleep disorders and improve overall health. However, some patients face…
Summary: In response to the often overwhelming and stressful online content surrounding baby sleep, experts have launched a mission to combat parent shaming and fear-mongering. The initiative aims to provide evidence-based, compassionate guidance that empowers parents without adding guilt or anxiety. The experts emphasize the importance of understanding each baby’s unique needs and promoting realistic…
Summary: Nxera Pharma, formerly known as Sosei Group, announced that its partner Centessa Pharmaceuticals has initiated a phase 2 trial of ORX750, an oral orexin receptor 2 agonist designed to treat narcolepsy type 1, type 2, and idiopathic hypersomnia. This milestone results in a $3.5 million payment to Nxera, which will be recognized as revenue…
Date and Time November 15, 202411:00 a.m.–12:00 p.m. ET OverviewIn this webinar, the National Autism Coordinator of the U.S. Department of Health and Human Services (HHS) and Director of the Office of National Autism Coordination (ONAC), Susan Daniels, Ph.D., will host an illuminating conversation with clinical psychologist and parent, Crystal Hernandez Psy.D., M.B.A. (Cherokee), advocate Jim…
Summary: SoundHealth has launched SONUCheck, an AI-powered feature in its app that uses vocal analysis to measure nasal patency. By leveraging machine learning, the app quantifies nasal breathing in real time, offering users personalized feedback to improve awareness of nasal versus mouth breathing. This feature addresses the health implications of mouth breathing, which is linked…